The IU Simon Comprehensive Cancer Center partners with several Indiana University centers and schools, private organizations and a hospital system to conduct its patient care, research and education. These partnerships bring together talents and resources, and strengthen efforts that are aimed at reducing the burden of cancer in Indiana and beyond.The American Cancer Society, together with millions of supporters, saves lives and creates a world with less cancer and more birthdays by helping people stay well, helping people get well, finding cures, and fighting back.
The Big Ten Cancer Research Consortium brings together the cancer centers of the Big Ten to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.
The Harper Cancer Research Institute is a partnership between the IU School of Medicine and the University of Notre Dame. Investigators at the Harper Cancer Research Institute are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer.
The Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, is an independent not-for-profit organization established to explore and develop leading-edge cancer treatments across the United States and internationally.
Indiana Institute for Personalized Medicine explores how genetic information and environmental exposure affect each person's risk to develop certain diseases and response to medication.
Indiana University Health is composed of the hospitals and clinics of the Indiana University School of Medicine, IU Health University Hospital, Riley Hospital for Children and Methodist Hospital. IU Health is committed to excellence in patient care, education and research.
The Indiana University School of Medicine is committed to providing high-quality graduate and continuing education that produces outstanding educators, physicians and scientists; conducting research to advance knowledge of health and behavior and to make discoveries leading to improved prevention and treatment of disease; and providing outstanding clinical care, which incorporates the latest advances in scientific knowledge. Many IU Simon Cancer Center members are IU School of Medicine faculty.
The National Cancer Institute is part of the National Institutes of Health and the Department of Health and Human Services. Its main responsibilities include coordinating the National Cancer Program; conducting and supporting cancer research; training physicians and scientists; and disseminating information about cancer detection, diagnosis, treatment, prevention, control, palliative care and survivorship.
The Purdue University Center for Cancer Research is an NCI-designated cancer center in West Lafayette, Ind., that conducts basic research. It is committed to helping cancer patients by identifying new molecular targets and designing future agents and drugs for effectively detecting and treating cancer.
The Regenstrief Institute is an internationally respected informatics and healthcare research organization, recognized for its role in improving quality of care, increasing efficiency of healthcare delivery, preventing medical errors and enhancing patient safety.
The Susan G. Komen Tissue Bank at the IU Simon Cancer Center strives to acquire biomolecule and tissue specimens from the entire continuum of breast development — puberty to menopause — and to make these specimens or the digital data derived from them available and accessible to researchers across the globe. It is the world’s first and only healthy breast tissue bank.
The Vera Bradley Foundation Center for Breast Cancer Research is focused on dramatically improving therapies for some of the most difficult-to-treat types of breast cancer. Its multi-disciplinary team of more than 30 breast cancer physicians and scientists are engaged in basic, translational and clinical research. They are capitalizing on new technologies to develop highly customized therapies and to help women avoid the life-altering side effects that often result from standard treatment.
The Walther Cancer Foundation is an independent, private grant-making foundation committed to eliminating cancer as a cause of suffering and death through supporting and promoting interdisciplinary and inter-institutional basic laboratory, clinical and behavioral cancer research.